“messenger-rna” Archives

in
Entry Author Date Location
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More 10/09/20 National
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
Pfizer, BioNTech Choose Full Spike Protein for Pivotal Vaccine Test 07/28/20 New York
Moderna Publishes Early COVID-19 Vaccine Data, Preps for Phase 3 Test 07/15/20 Boston
BioNTech’s mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity 07/01/20 Europe
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More 08/02/19 National
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
FDA Places Clinical Hold on Translate Bio’s mRNA Drug Study 01/22/19 Boston
Eyeing $500M, Moderna Outlines Plans for Biotech’s Biggest IPO Ever 11/09/18 Boston
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More 10/12/18 National
IPO Wave Rolls On as Five Life Science Firms Haul In $651M 06/28/18 National
Neon Therapeutics, Translate Bio Join the Ranks of IPO Hopefuls 06/04/18 Boston
Accent Therapeutics Debuts With $40M To Target RNA Modification 05/18/18 Boston
An Inside Look at CAR-T, Gene Therapy Launches at ‘What’s Hot’ May 16 05/09/18 Boston
With $23M, Flagship-Backed Sigilon Protects Protein-Producing Cells 06/21/17 Boston
RaNA Expands, Joins Messenger RNA Drug Race With Shire Deal 01/04/17 Boston
After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes? 10/18/16 Boston
Will Programmable Immune “Cellbots” Be the Next Weapon Against Cancer? 09/29/16 San Francisco
With New Startup, Caperna, Moderna Gets in on Cancer Vaccine Buzz 10/22/15 Boston
East Coast Biotech Roundup: Biogen, Watson, Data Dumps & More 09/11/15 Boston
CureVac Opens up an mRNA Hub in Moderna’s Cambridge Backyard 09/10/15 Boston
CRISPR Race Heats Up As Gates, Crossovers Put $120M Into Editas 08/10/15 Boston
RaNA CEO Renaud Turns To A Former Backer To Lead $55M Series B 07/23/15 Boston
Flagship CEO on Backing NY Biotech, Moderna, and Investing in a Boom 06/22/15 New York
Moderna’s Third mRNA Startup, Elpidera, Sets Sights on Rare Diseases 05/12/15 Boston
West Coast Biotech Roundup: Pharmacyclics, Gates, Ikaria & More 03/05/15 San Francisco
East Coast Biotech Roundup: Foundation, Biogen, Moderna, & Lots More 01/16/15 Boston
Moderna Forms Latest Venture, Valera, to Fight Infections With mRNA 01/08/15 Boston
With Massive Venture Round, Moderna Has $450M Reasons to Stay Private 01/05/15 Boston
Page 1 of 2 next page »